Free Trial
ASX:BLG

BluGlass (BLG) Stock Price, News & Analysis

BluGlass logo

About BluGlass Stock (ASX:BLG)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
20,002 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
4.49%
Price Target
N/A
Consensus Rating
N/A

Company Overview

BluGlass Limited, together with its subsidiaries, engages in the development of semiconductor manufacturing technology and devices for industrial, quantum, biotech, defense, and scientific markets in Australia and the United States. It develops and commercializes remote plasma chemical vapor deposition, a patented low temperature technology for manufacturing gallium nitride laser diodes, as well as provides foundry services. The company was founded in 2005 and is headquartered in Silverwater, Australia.

Receive BLG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BluGlass and its competitors with MarketBeat's FREE daily newsletter.

BLG Stock News Headlines

Top 5 ASX Technology Stocks (Updated January 2024)
BluGlass Limited Announces Director’s Interest Change
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
BluGlass Lands Major Contract for Laser Tech Development
BluGlass Advances in Photonics and Semiconductor Ventures
BluGlass Secures Major Development Deal with Uviquity
BluGlass Limited Shares Strategic Updates at AGM
BluGlass Limited Secures AGM Success and Future Growth
See More Headlines

BLG Stock Analysis - Frequently Asked Questions

BluGlass Limited (ASX:BLG) posted its earnings results on Thursday, February, 14th. The company reported ($0.01) earnings per share (EPS) for the quarter. BluGlass had a negative trailing twelve-month return on equity of 70.47% and a negative net margin of 219.53%.

Based on aggregate information from My MarketBeat watchlists, some other companies that BluGlass investors own include DarioHealth (DRIO), Immunomedics (IMMU), Sonic Healthcare (SHL), Endeavour Group (EDV) and Costa Group (CGC).

Company Calendar

Last Earnings
2/14/2019
Today
12/23/2024

Industry, Sector and Symbol

Industry
Semiconductor Equipment & Materials
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

Net Income
$-10,140,000.00
Net Margins
-219.53%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$4.62 million
Book Value
A$0.01 per share

Miscellaneous

Outstanding Shares
1,840,000,000
Free Float
N/A
Optionable
Not Optionable
Beta
1.06
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

This page (ASX:BLG) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners